ATRX and thalassemia: The only target of ATRX identified to date is α globin which is downregulated in patients with germline or somatic ATRX mutations [29], including α-thalassemia myelodysplastic syndrome [30], although evidence that ATRX directly binds to the α globin locus is still lacking.